similar. High concentrations of circulating cortisol are associated with excessive fat deposition in Cushing's syndrome and in obesity in experimental animals 131. Most human obesity is not associated with gross elevations of serum cortisol concentrations, but obesity may involve an increased sensitivity to glucocorticoid action [ 31. These hormones facilitate the action of insulin in stimulating the synthesis of fatty acids [4, 5] . Their effects on the synthesis of triacylglycerols in liver seem to be more direct and the available evidence indicates that they stimulate the synthesis of the enzyme phosphatidate phosphohydrolase [ 1, 21. The 'microsomal and soluble phosphatidate phosphohydrolase (Fig. 1) have a regulatory function, particularly in enabling the liver to synthesize increased quantities of triacylglycerol. This enzymic adaptation therefore partly explains why injections of corticotropin or glucocorticoids stimulate hepatic triacylglycerol synthesis [2, 61 and produce a fatty liver [7, 81 Glucocorticoids also promote the secretion of VLDL [9, 101.
The influence of glucocorticoids on the activity of phosphatidate phosphohydrolase is particularly apparent in stress conditions. This activity can increase in starvation [ l 1, 121, mildly ketotic diabetes [ 
.34).
[ 181 through its action on carnitine palmitoyltransferase. Lack of insulin has also been reported to decrease the activity of glycerophosphate acyltransferase, particularly that in the mitochondria1 fraction [ 191. These changes promote the partitioning of fatty acids into poxidation and ketogenesis rather than into esterification ( Fig. 1) . However, the supply of fatty acids to the liver often exceeds its need for energy production via ,&oxidation, and the excess acids and their acyl-CoA esters are potentially toxic. Their conversion into triacylglycerols enables them to be stored temporarily in a safe form and allows CoA to be regenerated. This explains why these stress conditions are often accompanied by a fatty liver.
The liver can also secrete this triacylglycerol provided that lipoprotein synthesis is not inhibited as it may be in some toxic conditions. This VLDL secretion can increase in ketotic diabetes [20] and, since insulin is required for the activity of lipoprotein lipase in adipose tissue, triacylglycerol clearance is decreased and a hypertriglyceridaemia results (Fig. 1) . The action of insulin in increasing lipoprotein lipase activity in adipose tissue can be potentiated by glucocorticoids [2 11. By contrast, the lipoprotein lipase activity in heart appears to be maintained primarily by glucocorticoids and insulin may promote this action [22]. This ability of the heart to oxidize and esterify fatty acids is also high in keototic diabetes 1231. In this condition the liver is supplying energy to the heart in the form of triacylglycerols and ketones, and to the brain as glucose and ketones. In this instance the control of hepatic phosphatidate phosphohydrolase by glucocorticoids appears to resemble their control of some enzymes of gluconeogenesis.
The diurnal peak of corticosterone in rats occurs about 4 h before the maximum food intake 1241. This peak is probably responsible for the increased synthesis of phosphatidate phosphohydrolase, so that its activity is greatest when the liver increases its synthesis of fatty acids. Nutrients such as glycerol, sorbitol, fructose and ethanol stimulate hepatic triacylglycerol synthesis. When these are given as acute loads to rats, they provoke a much larger glucocorticoid response than does the equivalent load of glucose and they do not increase insulin concentrations [251. . This alteration can also be understood in terms of the greater production of corticosteroids and the insulin insensitivity that can accompany fat feeding.
The discussion so far has been concerned with the effects of glucocorticoids on triacylglycerol and lipoprotein metabolism particularly in relation to the effects of insulin. Glucocorticoids stimulate triacylglycerol synthesis, VLDL secretion and therefore the flux of cholesterol into LDL. They may also aggravate insulin insensitivity. These actions could contribute to their observed effects in producing hypertriglyceridaemia and hypercholesterolaemia [46-481. Glucocorticoid Taken together these observations provide one possible link between many of the acknowledged risk factors associated with an increased incidence of atherosclerosis and changes in hormonal balance. This article has attempted to review how increases in the availability of glucocorticoids could modify the direction and rate of triacylglycerol synthesis and lipoprotein metabolism. It is hoped that this information may contribute to a better understanding of the biochemical changes that occur in complex metabolic diseases such as fatty liver, obesity, diabetes and atherosclerosis.
Conclusions
Glucocorticoids increase the activity and concentration of L-cc-phosphatidate phosphohydrolase (EC 3.1.3.4) in the liver. This enzyme has an important regulatory function and this change facilitates the increased synthesis, accumulation and secretion of triacylglycerols by the liver. The increased production of very-low-density lipoprotein also means that the ultimate flux of cholesterol into low-density lipoproteins is increased.
If insulin concentrations are low, or if there is insulin insensitivity, then the clearance of circulating triacylglycerol by adipose tissue decreases and a hypertriglyceridaemia may result.
The clearance of triacylglycerols by the heart can increase in relative terms, since its lipoprotein lipase activity is maintained by glucocorticoids rather than by insulin.
Changes in glucocorticoid status may be significant in determining the effects on metabolism of stress, diabetes, smoking and the consumption of diets deficient in ascorbate or rich in sucrose, sorbitol, ethanol and fat.
It is proposed that changes in glucocorticoid status that could occur in these conditions could contribute to the development of fatty livers, D. N . Brindley maturity onset diabetes, obesity and atherosclerosis.
